[1]龚玉静,郝燕燕#.睫状体光凝联合玻璃体腔内注射Avastin治疗新生血管性青光眼的临床观察[J].郑州大学学报(医学版),2011,(06):937.
点击复制

睫状体光凝联合玻璃体腔内注射Avastin治疗新生血管性青光眼的临床观察
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2011年06期
页码:
937
栏目:
应用研究
出版日期:
2011-11-20

文章信息/Info

作者:
龚玉静郝燕燕#
郑州大学第一附属医院眼科 郑州 450052
关键词:
新生血管性青光眼睫状体光凝Avastin

参考文献/References:

[1]卢振威,郝燕燕. 经巩膜睫状体半导体激光光凝治疗难治性青光眼50眼[J]. 郑州大学学报:医学版,2009,44(11):658 [2]Wasik A,Song HF,Grimes A,et al. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma[J]. Optometry, 2009,80(5):243 [3]SivakCallcott JA,O’Day DM,Gass JD,et al.Evidencebased recommendations for the diagnosis and treatment of neovascular glaucoma[J].Ophthalmology,2001,108(10):1767 [4]王光洁, 宋艳萍, 黄震晞,等.二极管激光睫状体光凝的眼压变化和病理表现[J]. 眼科新进展, 2002,22(1):25 [5]Liu GJ, Mizukawa A, Okisaka S. Mechanism of intraocular pressure decrease after contact transscleral continuouswave Nd:YAG laser cyclophotocoagulation[J]. Ophthalmic Res,1994,26(2):65 [6]Moshfeghi AA, Rosenfeld PJ, Puliafito CA, et al. Systemic bevacizumab(avastin) therapy for neovascular agerelated macular degeneration:twentyfourweek results of an uncontrolled, open label clinical study[J]. Ophthalmology,2006,113(11):2002.e1 [7]Rosenfeld PJ, Moshfeghi AA, Puliafitoc CA.Optical coherence tomography findings after an intravitreal injection of bevacizumab(avastin) for neovascular agerelated macular degeneration[J].Ophthalmic Surg Laser Imaging,2005,36(4):331 [8]Iliev ME, Domig D, WolfSchnurrbursch U, et al. Intravitral bevacizumab (Avastin) in the treatment of neovascular glaucoma [J]. Am J Ophthalmol,2006,142(6):1054

相似文献/References:

[1]卢振威,郝燕燕#.经巩膜睫状体半导体激光光凝治疗难治性青光眼50眼[J].郑州大学学报(医学版),2009,(03):658.

备注/Memo

备注/Memo:
#通讯作者,女,1952年9月生,教授,研究方向:青光眼、眼屈光,Email:haoyy52@hotmail.com
更新日期/Last Update: 1900-01-01